Want to join the conversation?
Pharmaceutical sourcing company $ABC said 3Q16 revenues were $36.9Bil, up 8%. The Pharmaceutical Distribution segment accounted for almost all the revenue growth. Adjusted gross profit increased 6% to $1.1Bil. The Pharmaceutical Distribution segment accounted for roughly 80% of gross profit dollar growth.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?